by The epigenetics market offers various solutions that helps alter gene expression without changing the DNA sequence. Epigenetics finds applications across various sectors including oncology, developmental biology, immunology, and others. Advancement in technologies is enabling researcher to improve their understanding of epigenetic modifications and facilitate the development of novel epigenetic-based therapies and diagnostic techniques.
The global epigenetics market size was valued at US$ 17.05 Bn in 2024 and is expected to reach US$ 29.13 Bn by 2030, growing at a CAGR of 7.2% during the forecast period.
Epigenetics solutions help identify disease risk and study changes made to regulate the expression of DNA during development and aging process. The products and services offered in this market aid in understanding how environmental factors and lifestyle choices impact individual health conditions.
Key Takeaways
Key players operating in the Global epigenetics market size are L’Oréal S.A, Procter and Gamble Company (P&G), Estee Lauder Companies Inc., The Unilever Plc, Shiseido Co. Ltd., Johnson and Johnson Limited, Kose Corporation, and Kao Corporation. These companies dominate the market with their diverse product portfolios and strong geographical presence.
The growing demand for epigenetics solutions across various therapeutic areas is driving the market growth. Rapid adoption of these solutions in oncology research activities and clinical diagnostics is fueling market revenues. Furthermore, rising funding for epigenetics research from government and private organizations is positively impacting the market.
Major players are focusing on geographical expansion strategies to capitalize on revenue potential from emerging markets. Strategic collaborations with research institutes and academic organizations is helping companies develop novel technologies and solutions. Rising healthcare investments from governments worldwide is creating conducive environment for long term market growth.
Market Key Trends
Technological advancements is a major trend shaping the epigenetics market. Integration of epigenetics with fields such as bioinformatics and computing is enabling development of high-throughput solutions. This is supporting detailed characterization of epigenomes and understanding the role of epigenetics in diseases. Furthermore, development of DNA sequencing technologies such as next generation and third generation sequencing is facilitating comprehensive epigenetic analysis. Adoption of artificial intelligence and machine learning algorithms is also increasing in this field to gain novel insights from large epigenomic datasets. Rising R&D investments by market players as well as government bodies is driving advancements in epigenetics platforms, tools and reagents. This will amplify market opportunities going forward.
Porter’s Analysis
Threat of new entrants: High costs associated with R&D prevents many new players from entering the market.
Bargaining power of buyers: Increasing research activities related to the field provides buyers with better options and negotiation power.
Bargaining power of suppliers: Suppliers hold relatively less bargaining power due specialized equipment and reagents required for research.
Threat of new substitutes: Opportunities for substitutes are low as epigenetics is still an evolving field with no close substitute alternatives available yet.
Competitive rivalry: Intense research competition exists among top players to gain first mover advantage and maximize market share.
Geographical Regions
North America dominates the global epigenetics market and holds the largest share in terms of value, owing to increasing focus on precision medicine and rising prevalence of cancer in the region. The presence of major market players and established research hubs further supports market growth.
Asia Pacific is anticipated to exhibit the fastest growth over the forecast period 2024-2030. This is attributed to developing research infrastructure, rising healthcare expenditures, and growing public awareness about early disease diagnosis in major APAC countries such as India and China. The region offers lucrative opportunities for contract research and manufacturing services as well.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
